PTPN1 and Alzheimer disease: In fact, preclinical studies have demonstrated that mice lacking PTP1B were resistant to weight gain and remained sensitive to insulin after HFD consumption [108, 109] suggesting that PTP1B downregulation could be key in order to improve the features observed in AD pathogenesis by the regulation of insulin signaling pathway and neuroinflammatory processes [110].